1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 7
2 Introduction 8
2.1 What Is This Report About? 8
2.2 Neuromodulation Devices Market Segmentation 8
2.3 Definitions of Markets Covered in the Report 9
3 Neuromodulation Devices Market, EU5 10
3.1 Neuromodulation Devices Market, EU5, Revenue ($m), 2015-2025 10
3.2 Neuromodulation Devices Market, EU5, Revenue ($m), 2015-2025 12
3.3 Neuromodulation Devices Market, EU5, Volume (Units), 2015-2025 15
3.4 Neuromodulation Devices Market, EU5, Volume (Units), 2015-2025 17
3.5 Neuromodulation Devices Market, EU5, Company Share by Revenue ($m), 2018 20
4 Neuromodulation Devices Market, France 22
4.1 Neuromodulation Devices Market, France, Revenue ($m), 2015-2025 22
4.2 Neuromodulation Devices Market, France, Volume (Units), 2015-2025 25
4.3 Neuromodulation Devices Market, France, Average Price ($), 2015-2025 28
4.4 Neuromodulation Devices Market, France, Distribution Share by Revenue ($m), 2018 30
4.5 Neuromodulation Devices Market, France, Company Share by Revenue ($m), 2018 31
5 Neuromodulation Devices Market, Germany 33
5.1 Neuromodulation Devices Market, Germany, Revenue ($m), 2015-2025 33
5.2 Neuromodulation Devices Market, Germany, Volume (Units), 2015-2025 36
5.3 Neuromodulation Devices Market, Germany, Average Price ($), 2015-2025 39
5.4 Neuromodulation Devices Market, Germany, Distribution Share by Revenue ($m), 2018 41
5.5 Neuromodulation Devices Market, Germany, Company Share by Revenue ($m), 2018 42
6 Neuromodulation Devices Market, Italy 44
6.1 Neuromodulation Devices Market, Italy, Revenue ($m), 2015-2025 44
6.2 Neuromodulation Devices Market, Italy, Volume (Units), 2015-2025 47
6.3 Neuromodulation Devices Market, Italy, Average Price ($), 2015-2025 50
6.4 Neuromodulation Devices Market, Italy, Distribution Share by Revenue ($m), 2018 52
6.5 Neuromodulation Devices Market, Italy, Company Share by Revenue ($m), 2018 53
7 Neuromodulation Devices Market, Spain 55
7.1 Neuromodulation Devices Market, Spain, Revenue ($m), 2015-2025 55
7.2 Neuromodulation Devices Market, Spain, Volume (Units), 2015-2025 58
7.3 Neuromodulation Devices Market, Spain, Average Price ($), 2015-2025 61
7.4 Neuromodulation Devices Market, Spain, Distribution Share by Revenue ($m), 2018 63
7.5 Neuromodulation Devices Market, Spain, Company Share by Revenue ($m), 2018 64
8 Neuromodulation Devices Market, United Kingdom 66
8.1 Neuromodulation Devices Market, United Kingdom, Revenue ($m), 2015-2025 66
8.2 Neuromodulation Devices Market, United Kingdom, Volume (Units), 2015-2025 69
8.3 Neuromodulation Devices Market, United Kingdom, Average Price ($), 2015-2025 72
8.4 Neuromodulation Devices Market, United Kingdom, Distribution Share by Revenue ($m), 2018 74
8.5 Neuromodulation Devices Market, United Kingdom, Company Share by Revenue ($m), 2018 75
9 Overview of Key Companies in EU5 Neuromodulation Devices Market 77
9.1 Medtronic Plc 77
9.1.1 Company Overview 77
9.2 Abbott Laboratories 77
9.2.1 Company Overview 77
9.3 Boston Scientific Corp 77
9.3.1 Company Overview 77
9.4 LivaNova PLC 77
9.4.1 Company Overview 77
9.5 Nevro Corp 78
9.5.1 Company Overview 78
10 Neuromodulation Devices Market Pipeline Products 79
11 Recent Developments 86
11.1 Corporate Communications 86
11.1.1 Nov 14, 2019: Medtronic highlights leadership in inclusion, diversity, and equity in 2019 integrated performance report 86
11.1.2 Nov 11, 2019: Dr. Leena Niemistö starts as new Chair of the Board of Nexstim 86
11.1.3 Oct 21, 2019: Sean Salmon named executive vice president and group president of Medtronic Diabetes 87
11.1.4 Oct 15, 2019: Changes in the Nexstim Board 88
11.1.5 Aug 28, 2019: Medtronic announces planned leadership succession 88
11.1.6 Aug 12, 2019: GSK announces leadership changes in the US 89
11.1.7 Jul 29, 2019: Sanofi: Appointment of additional director and whole time director 90
11.1.8 Jul 26, 2019: Sanofi : Information on the departure conditions of Olivier Brandicourt, Chief Executive Officer 90
11.1.9 Jul 25, 2019: Nexstim Plc: Change in members of the board committees 91
11.1.10 Jul 24, 2019: GlaxoSmithKline appoints Jonathan Symonds as Non-Executive Chairman of the Board of Directors 91
11.1.11 Jul 24, 2019: Former Medtronic Executive Sean Ginney named VP of Sales at Current Health 92
11.1.12 Jul 24, 2019: GlaxoSmithKline appoints Jonathan Symonds as Non-Executive Chairman of the Board of Directors 92
11.1.13 Jul 05, 2019: Gungor Kara appointed new Chief Digital Officer of Ottobock 93
11.1.14 Jun 24, 2019: Jorg Wahlers appointed new Chief Financial Officer 93
11.1.15 Jun 19, 2019: LivaNova welcomes Stacy Enxing Seng to Board of Directors 94
11.1.16 Jun 07, 2019: Paul Hudson to succeed Olivier Brandicourt as chief executive officer 95
11.1.17 Apr 24, 2019: Nexstim names Professor Paul Fitzgerald to Scientific Advisory Board 95
11.1.18 Apr 10, 2019: Professor Alvaro Pascual-Leone joins Nexstim scientific advisory board 96
11.1.19 Apr 05, 2019: Professor Linda Carpenter joins Nexstim's Scientific Advisory Board 96
11.1.20 Mar 29, 2019: PolarityTE announces Richard Hague, formerly from Sanofi, Genzyme and recently Anika Therapeutics as Chief Operating Officer 97
11.1.21 Mar 28, 2019: GlaxoSmithKline Pharmaceuticals: Change in directorate 97
11.1.22 Mar 18, 2019: LivaNova announces Trui Hebbelinck as Chief Human Resources Officer 98
11.1.23 Mar 14, 2019: Medtronic names Andrea J. Goldsmith as a new director 98
11.1.24 Mar 04, 2019: California Life Sciences Association (CLSA) adds GlaxoSmithKline and Blade Therapeutics to Board 99
11.1.25 Mar 01, 2019: Pius S. Hornstein, PhD, appointed new country chair of Sanofi China 99
11.1.26 Feb 12, 2019: Sanofi names Ameet Nathwani as chief digital officer 100
11.1.27 Feb 06, 2019: Sanofi's Board of Directors notes the resignation of Christian Mulliez and co-opts Christophe Babule as Director 101
11.1.28 Jan 22, 2019: Management Board appoints Philipp Schulte-Noelle as CEO 101
11.1.29 Jan 21, 2019: GlaxoSmithKline announces resignation of Sir Philip Hampton as non-executive chairman 102
11.1.30 Jan 21, 2019: GSK announces succession plan to appoint new Chairman 102
11.2 Financial Announcements 103
11.2.1 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019 103
11.2.2 Oct 31, 2019: Sanofi Q3 well on track 104
11.2.3 Oct 30, 2019: LivaNova reports third quarter 2019 results 107
11.2.4 Aug 20, 2019: Medtronic reports first quarter financial results for 2019 108
11.2.5 Aug 16, 2019: Nexstim half-yearly report 1 January – 30 June 2019 110
11.2.6 Jul 31, 2019: LivaNova reports second quarter 2019 results 111
11.2.7 Jul 29, 2019: Sanofi delivered solid growth in Q2 2019 112
11.2.8 Jul 24, 2019: Boston Scientific announces results for second quarter 2019 120
11.2.9 Jul 24, 2019: GSK delivers sales and earnings growth in Q2 2019 121
11.2.10 Jul 17, 2019: AorTech International: Final results for the year ended 31 March 2019 122
11.2.11 May 23, 2019: Medtronic announces fiscal year and fourth quarter 2019 financial results 124
11.2.12 May 07, 2019: Avanos Medical announces first quarter 2019 results 127
11.2.13 May 06, 2019: Continued profitable growth for Carl Zeiss Meditec 128
11.2.14 May 06, 2019: Carl Zeiss Meditec: First half year 2018/2019 129
11.2.15 May 01, 2019: LivaNova announces first quarter 2019 results 130
11.2.16 May 01, 2019: GSK delivers sales of £7.7 billion +6% AER, +5% CER 131
11.2.17 Apr 12, 2019: Carl Zeiss Meditec reports further growth and defines expectations for fiscal year 2018/19 132
11.2.18 Apr 05, 2019: LivaNova reports preliminary unaudited first quarter 2019 revenue results 132
11.2.19 Feb 27, 2019: LivaNova reports fourth quarter and full-year 2018 results 132
11.2.20 Feb 19, 2019: Medtronic reports third quarter financial results 134
11.2.21 Feb 11, 2019: Continued profitable growth for Carl Zeiss Meditec in the first three months of 2018/19 136
11.2.22 Feb 07, 2019: Sanofi delivers 2018 business EPS growth of
5.1% at CER 137
11.2.23 Feb 06, 2019: GSK delivers sales, earnings and cash flow growth in 2018 145
11.2.24 Jan 14, 2019: Carl Zeiss Meditec achieves strong revenue and EBIT growth in first three months 2018/19 146
11.3 Government and Public Interest 146
11.3.1 Jan 09, 2019: Medtronic Foundation Recognizes 12 Bakken Invitation Honorees for Driving Positive Change in Healthcare 146
11.4 Legal And Regulatory 147
11.4.1 Sep 13, 2019: Vectura provides update on GSK Litigation 147
11.4.2 Jul 16, 2019: Swiss agree to extradite Chinese researcher in US corporate espionage case 148
11.4.3 May 04, 2019: Vectura wins US GSK Patent Litigation and awarded $89.7Million in damages by Trial Jury 148
11.4.4 Feb 15, 2019: BRAVO BIDCO: Update on the proposed acquisition of BTG 149
11.4.5 Jan 22, 2019: Neovasc Announces Dismissal of Claim brought by Edwards Lifesciences 149
11.5 Other Significant Developments 149
11.5.1 Oct 22, 2019: EPFL spin-off GTX medical moves into the US market 149
11.5.2 Sep 10, 2019: Kazan Federal University and Mayo Clinic implement unique rehabilitation technology to treat spinal cord injuries 150
11.5.3 May 23, 2019: Ottobock creates considerable value 151
11.5.4 May 14, 2019: AorTech International: Trading update 152
11.5.5 Apr 26, 2019: Sanofi delivers strong Q1 2019 business EPS growth of
9.4% at CER 152
11.5.6 Apr 10, 2019: SANUWAVE provides an update on international registrations received, attendance at Trade Shows and ISO Certification 158
11.5.7 Mar 28, 2019: GSK publishes product sales reporting changes and the impact of IFRS 16 'Leases' 159
11.5.8 Mar 26, 2019: Nexstim publishes prospectus regarding EUR
5.2 million rights issue and new information regarding previous profit forecast 160
11.5.9 Mar 25, 2019: Medtronic launches Medtech Innovation Accelerator in Shanghai 161
11.5.10 Mar 12, 2019: GlaxoSmithKline: Publication of 2018 annual report 162
11.5.11 Mar 11, 2019: New genetic data from Regeneron and GSK on 50,000 UK Biobank participants made available to global health research community 176
11.5.12 Jan 24, 2019: AorTech International: Company Update 177
11.5.13 Jan 23, 2019: Sanofi joins Startup Creasphere – Munich's first digital health focused innovation program 178
11.5.14 Jan 11, 2019: Pre-quarterly results communication 179
11.6 Product News 181
11.6.1 Nov 11, 2019: Simulation-based approach for epilepsy receives regulatory approval 181
11.6.2 Jul 02, 2019: Swiss researchers study personalised neurotechnology stroke therapy 181
11.6.3 May 28, 2019: Brain stimulation may improve sight recovery after stroke 182
11.7 Strategy And Business Planning 182
11.7.1 Oct 15, 2019: Sanofi opens digital manufacturing facility in the US 182
11.7.2 Jun 24, 2019: Boston Scientific Galway expands in to new facility 183
11.7.3 Jun 21, 2019: GSK to raise $1.26bn by selling consumer health brands 184
11.7.4 May 21, 2019: Verily forms strategic alliances with Novartis, Otsuka, Pfizer and Sanofi to transform clinical research 184
12 Appendix 186
12.1 Research Methodology 187
12.1.1 Coverage 187
12.1.2 Secondary Research 187
12.1.3 Primary Research 188
12.1.4 Market Modeling and Forecasting 189
12.1.5 Company Share Analysis 190
12.1.6 Distribution Share Analysis 191
12.1.7 Benchmarking 191
12.2 GlobalData Consulting 192
12.3 Contact Us 192
12.4 Disclaimer 192
